Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-31In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-6Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-92Dendritic cells and chronic hepatitis virus carriers
/in Chronic Virus Hepatitis, International Publications /von 2001-01-01 / Intervirology 2001;44(4):199-208IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution